{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:10:47Z","timestamp":1788606647034,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cientificas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Our previous findings demonstrated that the B\n                    <jats:sub>2<\/jats:sub>\n                    T dendrimer peptide, harboring B- and T-cell foot-and-mouth disease virus (FMDV) epitopes, confers protection in swine and elicits in mice significant levels of neutralizing antibodies, a key correlate of protection against FMDV. Here, we use a mouse model to study the germinal center (GC) B-cell response in B\n                    <jats:sub>2<\/jats:sub>\n                    T-immunized mice, as this peptide is aimed to enhance antigen-specific immune responses, relying on T-cell help to potentiate B-cell activation and maturation. Flow cytometry revealed that immunization with B\n                    <jats:sub>2<\/jats:sub>\n                    T enhanced GC formation and increased the proportion of IgG1-positive GC B-cells in draining lymph nodes. Additionally, elevated levels of IgG1-secreting B-cells in bone marrow are consistent with the initiation of GC\u2013derived plasma cell differentiation, highlighting B\n                    <jats:sub>2<\/jats:sub>\n                    T\u2019s ability to potentiate antigen-specific immunity through coordinated B- and T-cell activation. The study demonstrated that only B\n                    <jats:sub>2<\/jats:sub>\n                    T, but not the version lacking T-cell epitope (B\n                    <jats:sub>2<\/jats:sub>\n                    ), triggered neutralizing antibody production and a robust T-cell response in the spleen, underscoring the critical role of CD4\n                    <jats:sup>+<\/jats:sup>\n                    T-cell help mediated by the T-cell epitope in eliciting protective immunity. Even though these studies need to be extended to natural hosts such as swine, our results highlight the role of the B\n                    <jats:sub>2<\/jats:sub>\n                    T dendrimer in inducing IgG1-secreting long-lived plasma cells in the bone marrow, providing insights into the mechanisms underlying the durable immunity elicited by epitope-linked dendrimer vaccines.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-42982-2","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:52:24Z","timestamp":1773280344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Foot-and-mouth disease virus-derived dendrimer peptides induce germinal center-dependent antibody responses and IgG1 plasma cell differentiation in mice"],"prefix":"10.1038","volume":"16","author":[{"given":"Marta","family":"Iborra-Pernichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"de Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sira","family":"Defaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Mart\u00ednez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Sobrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"42982_CR1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000578","volume":"147","author":"SD Blacksell","year":"2019","unstructured":"Blacksell, S. D., Siengsanan-Lamont, J., Kamolsiripichaiporn, S., Gleeson, L. J. & Windsor, P. A. A history of FMD research and control programmes in Southeast Asia: Lessons from the past informing the future. Epidemiol. Infect. 147, e171. https:\/\/doi.org\/10.1017\/S0950268819000578 (2019).","journal-title":"Epidemiol. Infect."},{"key":"42982_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000050","volume":"4","author":"EM Cottam","year":"2008","unstructured":"Cottam, E. M. et al. Transmission pathways of Foot-and-Mouth Disease virus in the United Kingdom in 2007. PLoS Pathog. 4, e1000050. https:\/\/doi.org\/10.1371\/journal.ppat.1000050 (2008).","journal-title":"PLoS Pathog."},{"key":"42982_CR3","unstructured":"WOAH. Statement on Recent Foot and Mouth Disease (FMD) Outbreak in Germany, https:\/\/www.woah.org\/en\/statement-on-recent-foot-and-mouth-disease-fmd-outbreak-in-germany\/ (2025)."},{"key":"42982_CR4","unstructured":"Bureau, B. A. Foot and Mouth Disease in Hungary Slovakia, https:\/\/www.britishagriculturebureau.co.uk\/updates-and-information\/foot-and-mouth-disease-in-hungary-and-slovakia-what-do-we-know-so-far\/ (2025)."},{"key":"42982_CR5","doi-asserted-by":"crossref","unstructured":"McCullough, K. a. S., F. Ch. Immunology of foot-and-mouth disease. In Foot-and-Mouth Disease Current Perspectives (eds Domingo, E. & Sobrino, F.) 173\u2013222 (Horizon Bioscience, 2004).","DOI":"10.1201\/9781420037968.ch8"},{"key":"42982_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev.immunol.15.1.235","volume":"15","author":"MF Bachmann","year":"1997","unstructured":"Bachmann, M. F. & Zinkernagel, R. M. Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15, 235\u2013270. https:\/\/doi.org\/10.1146\/annurev.immunol.15.1.235 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"42982_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","volume":"40","author":"GD Victora","year":"2022","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 40, 413\u2013442. https:\/\/doi.org\/10.1146\/annurev-immunol-120419-022408 (2022).","journal-title":"Annu. Rev. Immunol."},{"key":"42982_CR8","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1073\/pnas.85.15.5409","volume":"85","author":"JP Tam","year":"1988","unstructured":"Tam, J. P. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. U. S. A. 85, 5409\u20135413. https:\/\/doi.org\/10.1073\/pnas.85.15.5409 (1988).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"42982_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050477","author":"M Forner","year":"2021","unstructured":"Forner, M. et al. Peptide-based vaccines: Foot-and-Mouth Disease Virus, a paradigm in animal health. Vaccines https:\/\/doi.org\/10.3390\/vaccines9050477 (2021).","journal-title":"Vaccines"},{"key":"42982_CR10","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/tbed.13497","volume":"67","author":"R Canas-Arranz","year":"2020","unstructured":"Canas-Arranz, R. et al. A bivalent B-cell epitope dendrimer peptide can confer long-lasting immunity in swine against Foot-and-Mouth Disease. Transbound. Emerg. Dis. 67, 1614\u20131622. https:\/\/doi.org\/10.1111\/tbed.13497 (2020).","journal-title":"Transbound. Emerg. Dis."},{"key":"42982_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature12966","volume":"507","author":"BE Correia","year":"2014","unstructured":"Correia, B. E. et al. Proof of principle for epitope-focused vaccine design. Nature 507, 201\u2013206. https:\/\/doi.org\/10.1038\/nature12966 (2014).","journal-title":"Nature"},{"key":"42982_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.vetmic.2012.09.007","volume":"162","author":"H Zhang","year":"2013","unstructured":"Zhang, H., Li, Y., Huang, X. & Zheng, C. Global transcriptional analysis of model of persistent FMDV infection reveals critical role of host cells in persistence. Vet. Microbiol. 162, 321\u2013329. https:\/\/doi.org\/10.1016\/j.vetmic.2012.09.007 (2013).","journal-title":"Vet. Microbiol."},{"key":"42982_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01274-y","volume":"10","author":"E Blanco","year":"2025","unstructured":"Blanco, E. et al. Single dose of foot-and-mouth disease peptide vaccine fully protects swine and achieves intraserotype crossed neutralization. NPJ Vaccines 10, 216. https:\/\/doi.org\/10.1038\/s41541-025-01274-y (2025).","journal-title":"NPJ Vaccines"},{"key":"42982_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8010019","author":"R Canas-Arranz","year":"2020","unstructured":"Canas-Arranz, R. et al. A single dose of dendrimer B(2)T peptide vaccine partially protects pigs against Foot-and-Mouth Disease Virus infection. Vaccines (Basel) https:\/\/doi.org\/10.3390\/vaccines8010019 (2020).","journal-title":"Vaccines (Basel)"},{"key":"42982_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030513","author":"P de Leon","year":"2020","unstructured":"de Leon, P. et al. Association of porcine swine leukocyte antigen (SLA) haplotypes with B- and T-cell immune response to Foot-and-Mouth Disease Virus (FMDV) peptides. Vaccines https:\/\/doi.org\/10.3390\/vaccines8030513 (2020).","journal-title":"Vaccines"},{"key":"42982_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.621537","volume":"11","author":"P de Leon","year":"2020","unstructured":"de Leon, P. et al. Swine T-cells and specific antibodies evoked by peptide dendrimers displaying different FMDV T-cell epitopes. Front. Immunol. 11, 621537. https:\/\/doi.org\/10.3389\/fimmu.2020.621537 (2020).","journal-title":"Front. Immunol."},{"key":"42982_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.00498","volume":"7","author":"R Canas-Arranz","year":"2020","unstructured":"Canas-Arranz, R. et al. Immunogenicity of a dendrimer B(2)T peptide harboring a T-cell epitope from FMDV non-structural protein 3D. Front. Vet. Sci. 7, 498. https:\/\/doi.org\/10.3389\/fvets.2020.00498 (2020).","journal-title":"Front. Vet. Sci."},{"key":"42982_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/475960","volume":"2013","author":"E Blanco","year":"2013","unstructured":"Blanco, E. et al. B epitope multiplicity and B\/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines. Clin. Dev. Immunol. 2013, 475960. https:\/\/doi.org\/10.1155\/2013\/475960 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"42982_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26164714","author":"R Canas-Arranz","year":"2021","unstructured":"Canas-Arranz, R. et al. Immunogenicity of Foot-and-Mouth Disease Virus dendrimer peptides: Need for a T-cell epitope and ability to elicit heterotypic responses. Molecules https:\/\/doi.org\/10.3390\/molecules26164714 (2021).","journal-title":"Molecules"},{"key":"42982_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0378-1135(92)90106-4","volume":"30","author":"KC McCullough","year":"1992","unstructured":"McCullough, K. C. et al. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet. Microbiol. 30, 99\u2013112. https:\/\/doi.org\/10.1016\/0378-1135(92)90106-4 (1992).","journal-title":"Vet. Microbiol."},{"key":"42982_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nri3795","volume":"15","author":"SL Nutt","year":"2015","unstructured":"Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M. & Corcoran, L. M. The generation of antibody-secreting plasma cells. Nat. Rev. Immunol. 15, 160\u2013171. https:\/\/doi.org\/10.1038\/nri3795 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"42982_CR22","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.immuni.2021.07.015","volume":"54","author":"C Young","year":"2021","unstructured":"Young, C. & Brink, R. The unique biology of germinal center B cells. Immunity 54, 1652\u20131664. https:\/\/doi.org\/10.1016\/j.immuni.2021.07.015 (2021).","journal-title":"Immunity"},{"key":"42982_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","volume":"596","author":"JS Turner","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109\u2013113. https:\/\/doi.org\/10.1038\/s41586-021-03738-2 (2021).","journal-title":"Nature"},{"key":"42982_CR24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240668","author":"KM McIntire","year":"2024","unstructured":"McIntire, K. M. et al. Maturation of germinal center B cells after influenza virus vaccination in humans. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20240668 (2024).","journal-title":"J. Exp. Med."},{"key":"42982_CR25","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1099\/vir.0.068270-0","volume":"95","author":"M Habiela","year":"2014","unstructured":"Habiela, M. et al. Laboratory animal models to study foot-and-mouth disease: A review with emphasis on natural and vaccine-induced immunity. J. Gen. Virol. 95, 2329\u20132345. https:\/\/doi.org\/10.1099\/vir.0.068270-0 (2014).","journal-title":"J. Gen. Virol."},{"key":"42982_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.virol.2004.11.005","volume":"332","author":"FJ Salguero","year":"2005","unstructured":"Salguero, F. J., Sanchez-Martin, M. A., Diaz-San Segundo, F., de Avila, A. & Sevilla, N. Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice. Virology 332, 384\u2013396. https:\/\/doi.org\/10.1016\/j.virol.2004.11.005 (2005).","journal-title":"Virology"},{"issue":"1","key":"42982_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.immuni.2017.11.023","volume":"48","author":"RK Abbott","year":"2018","unstructured":"Abbott, R. K. et al. Precursor frequency and affinity determine B cell competitive fitness in germinal centers, tested with germline-targeting HIV vaccine immunogens. Immunity 48(1), 133\u2013146. https:\/\/doi.org\/10.1016\/j.immuni.2017.11.023 (2018).","journal-title":"Immunity"},{"key":"42982_CR28","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1084\/jem.20190164","volume":"216","author":"T Bancroft","year":"2019","unstructured":"Bancroft, T. et al. Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes. J. Exp. Med. 216, 2331\u20132347. https:\/\/doi.org\/10.1084\/jem.20190164 (2019).","journal-title":"J. Exp. Med."},{"key":"42982_CR29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.immuni.2020.08.001","volume":"53","author":"Y Kato","year":"2020","unstructured":"Kato, Y. et al. Multifaceted effects of antigen valency on B cell response composition and differentiation in vivo. Immunity 53, 548\u2013563. https:\/\/doi.org\/10.1016\/j.immuni.2020.08.001 (2020).","journal-title":"Immunity"},{"key":"42982_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/329547a0","volume":"329","author":"DR Milich","year":"1987","unstructured":"Milich, D. R., McLachlan, A., Thornton, G. B. & Hughes, J. L. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329, 547\u2013549. https:\/\/doi.org\/10.1038\/329547a0 (1987).","journal-title":"Nature"},{"key":"42982_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04194-22","volume":"11","author":"Y Song","year":"2023","unstructured":"Song, Y. et al. A synthetic SARS-CoV-2-Derived T-Cell and B-Cell peptide cocktail elicits full protection against lethal Omicron BA.1 infection in H11-K18-hACE2 mice. Microbiol. Spectr. 11, e0419422. https:\/\/doi.org\/10.1128\/spectrum.04194-22 (2023).","journal-title":"Microbiol. Spectr."},{"key":"42982_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virusres.2017.05.020","volume":"238","author":"JA Bohorquez","year":"2017","unstructured":"Bohorquez, J. A. et al. A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus. Virus Res. 238, 8\u201312. https:\/\/doi.org\/10.1016\/j.virusres.2017.05.020 (2017).","journal-title":"Virus Res."},{"key":"42982_CR33","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1016\/j.vaccine.2017.10.094","volume":"35","author":"L Du","year":"2017","unstructured":"Du, L. et al. Long-term humoral immunity induced by CVC1302-adjuvanted serotype O foot-and-mouth disease inactivated vaccine correlates with promoted T follicular helper cells and thus germinal center responses in mice. Vaccine 35, 7088\u20137094. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.094 (2017).","journal-title":"Vaccine"},{"key":"42982_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.antiviral.2016.03.005","volume":"129","author":"E Blanco","year":"2016","unstructured":"Blanco, E. et al. Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide. Antivir. Res. 129, 74\u201380. https:\/\/doi.org\/10.1016\/j.antiviral.2016.03.005 (2016).","journal-title":"Antivir. Res."},{"key":"42982_CR35","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1128\/JVI.00401-08","volume":"82","author":"C Cubillos","year":"2008","unstructured":"Cubillos, C. et al. Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J. Virol. 82, 7223\u20137230. https:\/\/doi.org\/10.1128\/JVI.00401-08 (2008).","journal-title":"J. Virol."},{"key":"42982_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1021\/bc300515t","volume":"24","author":"M Monso","year":"2013","unstructured":"Monso, M., de la Torre, B. G., Blanco, E., Moreno, N. & Andreu, D. Influence of conjugation chemistry and B epitope orientation on the immune response of branched peptide antigens. Bioconjug. Chem. 24, 578\u2013585. https:\/\/doi.org\/10.1021\/bc300515t (2013).","journal-title":"Bioconjug. Chem."},{"key":"42982_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0168-1702(99)00089-1","volume":"64","author":"M Toja","year":"1999","unstructured":"Toja, M., Escarmis, C. & Domingo, E. Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. Virus Res. 64, 161\u2013171. https:\/\/doi.org\/10.1016\/s0168-1702(99)00089-1 (1999).","journal-title":"Virus Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42982-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42982-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42982-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:05:16Z","timestamp":1776899116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42982-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42982"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42982-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have been involved in the preparation of this manuscript and consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All work involving live FMDV was carried out at the Centro de Investigaci\u00f3n en Sanidad Animal (CISA; INIA-CSIC), a facility authorised under Spanish and European legislation (EU Regulations 2016\/429 and 2017\/625) for in vivo and in vitro handling of FMDV. CISA operates a dedicated BSL3 laboratory for FMDV research that complies with EU biosecurity standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Biosafety and biosecurity statement"}}],"article-number":"13198"}}